Can Stallion sustain Q1's margin burst as helium facility ramps?
Strong Q1 earnings beat on volume growth and operational leverage set a high bar. Q2 will test whether the newly commissioned Semiconductor Gas facility can maintain momentum into the seasonally softer half, and whether margins hold near record highs.
The bar: Q1 set a high one
Stallion India Fluorochemicals posted a blowout Q1 FY27: standalone revenue climbed 9.9% YoY and 10.4% QoQ to ₹121.45 Cr, while net profit surged 79% YoY to ₹18.57 Cr, with EBITDA margins expanding sharply. The company signalled strong operating leverage from its core specialty chemicals (refrigerants, fluorine-based intermediates) alongside early contributions from recently commissioned capacity (the 10,000 MTPA R-32 facility came online by August). For Q2, investors will watch whether this momentum persists and whether the newly commissioned Semiconductor & Specialty Gas facility (Khalapur, commenced September 2026) begins to add material revenue.
~₹120–128 Cr
On-plan growth trajectory: +7–11% YoY (mid-range ₹124 Cr), +1–5% QoQ. Semiconductor Gas facility began ops in Sep; contribution likely marginal in Q2 as startup ramp takes time.
~14–15%
Q1 delivered 15.2% (₹18.57 Cr PAT on ₹121.45 Cr revenue) — a 150bps expansion. Normalization to 14–15% is on-plan; margins may face minor seasonal/input headwinds in Q2.
~₹20–23 Cr
Estimate based on 16–18% EBITDA margin (typical post-expansion), supporting prior guidance on operating leverage.
What on-plan vs weak looks like
On-plan: Revenue ₹122–126 Cr (7–10% YoY growth), PAT ₹17–19 Cr (14–15% margin). This marks solid sequential momentum with the foundry base holding and helium facility adding low single-digit ₹ Cr revenue in its first full operational quarter. EBITDA margin stable ~16–17%. The company maintains its FY28 guidance (>₹1,100 Cr revenue, 15% PAT margin) without commentary shifts. Weak: Revenue misses ₹120 Cr (growth <7% YoY) or PAT drops below ₹16 Cr (margin <13%). This could signal helium facility delays, softness in refrigerant/fluoro-intermediate demand, or margin pressure from raw material costs. Input inflation (HF, chlorine, energy) is a watch point in specialty chemicals, and any supply-chain disruption to the new facility would be flagged.
On track for FY27–28 guidance?
The company guided for FY28 revenue >₹1,100 Cr with a 15% PAT margin. At the current run-rate — Q1 at ~₹490 Cr annualized revenue, and assuming Q2–Q4 average ~₹120 Cr/quarter — FY27 revenue could land ~₹460–480 Cr (roughly in line with a prior-year base for a 10–12% ramp year). The new Semiconductor Gas facility should materially pull FY28 into the >₹1,100 Cr zone if ramp proceeds on schedule (full capacity contribution expected in H2 FY27–H1 FY28). Q2 will be the first test of this facility in a full operating quarter. Any slippage in ramp or demand would jeopardise the FY28 target.
Since last quarter: the filings scan
Semiconductor Gas facility live (Sep 19): Commercial operations commenced at the Khalapur debulking and blending plant — a strategic move into high-margin specialty gases (high-purity helium, neon, argon for semiconductor/electronics). The facility is designed for 1,200 MT annual capacity; contribution in Q2 will be early-stage ramp. GST inspection closed (Oct 15): Maharashtra State GST authorities completed their inspection and search at the registered office. The company cooperated and settled tax liability. Routine compliance closure — no material regulatory overhang flagged. Trading window closed (Sep 28): Compliance-driven closure ahead of result announcement. No insider-trading red flags reported in the block-deal data (Junomoneta bulk trades in July were buy/sell pairs at ₹205 — routine liquidity flow). Promoter stake steady: Shareholding: FII 0.83%, DII 1.53%, Promoter 47.80% (Q1 FY27). No major stock pledge or dilution signals in recent filings.
1 · Semiconductor Gas revenue & margin
How much did the helium/specialty gas facility contribute in its first full quarter? Look for commentary on utilization rates, pricing, and when management expects full-capacity contribution. This will calibrate FY28 growth.
2 · Core refrigerant/fluoro demand trajectory
Stripped of the helium facility, is the base business (R-32, HFC-410A, fluorine intermediates) holding growth? Demand signals here indicate whether the 7–11% YoY growth is sustainable or facing seasonal/cyclical headwinds.
3 · Input costs & margin guidance
Q1 saw 150bps margin expansion — unprecedented. Is this a durable uplift (pricing power, mix shift, scale) or a one-time beat that normalizes? Input inflation (HF, energy) is a risk in specialty chemicals. Listen for commentary on cost trajectory and revised FY27–28 margin guidance.
Stallion India Fluorochemicals faces a credibility test in Q2: can it sustain Q1's margin fireworks and demonstrate that the new Semiconductor Gas facility is a real growth driver, not a one-time capacity sink? Revenue is likely on-plan at ₹120–128 Cr (7–11% YoY growth), but the margin story — whether it holds near Q1's 15.2% or normalizes lower — will determine whether the market retains confidence in the FY28 >₹1,100 Cr target.
The stock at ₹196.88 is down 45% from all-time highs but up 98% from 52-week lows, reflecting the volatility of specialty-chemical micro-caps. Catalyst clusters (facility ramp, margin trajectory, any M&A or capacity expansion announcements) are key to re-rating higher. Watch for early-ramp commentary and demand signals from the semiconductor gas side on Nov 13.
Informational and educational content only. Not investment advice.